Xeris Pharmaceuticals Raises $6M

Austin-based Xeris Pharmaceuticals said Monday that it raised almost $6M in funding in 2012. The firm said the funding included funds from angel investors, the Texas Emerging Technologies Fund (TETF), as well as National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants and private foundation funding. Xeris is developing injectable treatments for diabetes, epilepsy, and other diseases. The firm explained that it received $336,793 as part of an SBIR grant in August of 2012, and a possible $1.05M in Phase II SBIR funding, a convertible note of $1.75M from its angel investors in November, and a $1.9M investment from the TETF. More information »